Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a -14.305% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
[a] Cc1nnc(NC(=O)c2cccc(S(=O)(=O)N3CC(c4ccccc4)CC3=O)c2)s1
[b] O=C1NCCN(Cc2ccc(Cl)c(F)c2)C1CC(=O)N1CCCO1
[c] Cc1ccc(CCN2C(=O)CCC2(C)C(=O)NCc2cccnc2)cc1
[d] O=C(NCCCNc1ccc([N+](=O)[O-])cc1Cl)c1ccccc1F
[e] Cc1cc(C(=O)COC(=O)c2ccc[nH]c2=O)c(C)n1-c1ccc(F)cc1
Answer: c. Cc1ccc(CCN2C(=O)CCC2(C)C(=O)NCc2cccnc2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(CCN2C(=O)CCC2(C)C(=O)NCc2cccnc2)cc1
Cc1ccc(CCN2C(=O)CCC2(C)C(=O)NCc2cccnc2)cc1
2-methyl-1-[2-(4-methylphenyl)ethyl]-5-oxo-N-(pyridin-3-ylmethyl)pyrrolidine-2-carboxamide